Pharmacological targeting of netrin-1 inhibits EMT in cancer.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 04 04 2022
accepted: 26 06 2023
pmc-release: 01 02 2024
medline: 11 8 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

Epithelial-to-mesenchymal transition (EMT) regulates tumour initiation, progression, metastasis and resistance to anti-cancer therapy

Identifiants

pubmed: 37532929
doi: 10.1038/s41586-023-06372-2
pii: 10.1038/s41586-023-06372-2
pmc: PMC7615210
mid: EMS188994
doi:

Substances chimiques

Netrin Receptors 0
Netrin-1 158651-98-0
RNA, Small Interfering 0
Antibodies, Monoclonal 0
Unc5b protein, mouse 0
Epithelial Cell Adhesion Molecule 0
TGFB1 protein, human 0
Transforming Growth Factor beta1 0
Ntn1 protein, mouse 0
NTN1 protein, human 0

Banques de données

ClinicalTrials.gov
['NCT02977195']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

402-408

Subventions

Organisme : European Research Council
ID : 885093
Pays : International

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

EMBO J. 2012 Dec 12;31(24):4563-75
pubmed: 23188079
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16210-5
pubmed: 15520390
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4850-5
pubmed: 18353983
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629
pubmed: 28397828
Sci Rep. 2020 Mar 23;10(1):5224
pubmed: 32251318
Mol Oncol. 2017 Jul;11(7):878-891
pubmed: 28544151
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cancer Cell. 2021 Aug 9;39(8):1150-1162.e9
pubmed: 34115987
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
Dev Cell. 2021 Dec 6;56(23):3174-3176
pubmed: 34875220
Nat Rev Mol Cell Biol. 2020 Jun;21(6):341-352
pubmed: 32300252
Cell Stem Cell. 2017 Feb 2;20(2):191-204.e5
pubmed: 27889319
Semin Oncol. 2012 Apr;39(2):145-9
pubmed: 22484186
Cancer Res. 2019 Jul 15;79(14):3651-3661
pubmed: 31088838
Gastroenterology. 2008 Oct;135(4):1248-57
pubmed: 18692059
Nat Genet. 2001 Dec;29(4):418-25
pubmed: 11694875
Dig Dis Sci. 2014 Jun;59(6):1213-21
pubmed: 24442237
Trends Cell Biol. 2019 Mar;29(3):212-226
pubmed: 30594349
Nat Commun. 2021 Nov 25;12(1):6876
pubmed: 34824236
Database (Oxford). 2019 Jan 1;2019:
pubmed: 30951143
Cancer Cell. 2016 Feb 8;29(2):173-85
pubmed: 26859457
Gigascience. 2018 Jul 1;7(7):
pubmed: 30010766
EMBO J. 2021 Sep 15;40(18):e108647
pubmed: 34459003
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17146-51
pubmed: 19721007
EMBO Mol Med. 2021 Nov 8;13(11):e14495
pubmed: 34542930
Cancer Cell. 2004 Apr;5(4):375-87
pubmed: 15093544
Nat Biotechnol. 2019 May;37(5):547-554
pubmed: 30936559
Respir Res. 2005 Jun 09;6:56
pubmed: 15946381
Clin Cancer Res. 2016 Feb 1;22(3):609-20
pubmed: 26420858
Cancer Discov. 2019 Aug;9(8):1102-1123
pubmed: 31197017
Nat Methods. 2019 Dec;16(12):1289-1296
pubmed: 31740819
Am J Cancer Res. 2015 Mar 15;5(4):1396-409
pubmed: 26101705
Oncotarget. 2016 Apr 26;7(17):24510-26
pubmed: 27014910
Cancer Res. 2020 Feb 15;80(4):747-756
pubmed: 31806640
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Exp Med. 2009 Apr 13;206(4):833-47
pubmed: 19349462
Tumour Biol. 2017 Apr;39(4):1010428317698388
pubmed: 28443497
Int J Oncol. 2019 Apr;54(4):1457-1465
pubmed: 30968155
Nat Cell Biol. 2014 Jun;16(6):488-94
pubmed: 24875735
Cancer. 1991 Apr 15;67(8):2030-2
pubmed: 2004320
Nature. 2018 Apr;556(7702):463-468
pubmed: 29670281
Gastroenterology. 2010 Apr;138(4):1595-606, 1606.e1-8
pubmed: 20080097
BMC Dev Biol. 2001;1:4
pubmed: 11299042
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
Sci Rep. 2019 Mar 26;9(1):5233
pubmed: 30914743
Trends Cell Biol. 2015 Nov;25(11):675-686
pubmed: 26437589
Cell Rep. 2019 Nov 5;29(6):1458-1468.e3
pubmed: 31693888
EMBO Mol Med. 2013 Dec;5(12):1821-34
pubmed: 24293316
Cancer Gene Ther. 2018 Feb;25(1-2):18-26
pubmed: 29234153
J Korean Med Sci. 2007 Oct;22(5):898-904
pubmed: 17982242
EMBO Mol Med. 2014 Sep 11;6(10):1279-93
pubmed: 25214461
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Nat Rev Cancer. 2021 May;21(5):325-338
pubmed: 33547455
Nat Rev Cancer. 2004 Dec;4(12):978-87
pubmed: 15573119
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923

Auteurs

Justine Lengrand (J)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.
NETRIS Pharma, Lyon, France.
Laboratory Apoptosis, Cancer and Development, Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institute PLAsCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Lyon, France.

Ievgenia Pastushenko (I)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Sebastiaan Vanuytven (S)

Department of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.
Laboratory of Multi-omic Integrative Bioinformatics, Center for Human Genetics, KU Leuven, Leuven, Belgium.

Yura Song (Y)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

David Venet (D)

Laboratory of Breast Cancer Translational Research J.-C. Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.

Rahul M Sarate (RM)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Melanie Bellina (M)

NETRIS Pharma, Lyon, France.
Laboratory Apoptosis, Cancer and Development, Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institute PLAsCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Lyon, France.

Virginie Moers (V)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Alice Boinet (A)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Alejandro Sifrim (A)

Laboratory of Multi-omic Integrative Bioinformatics, Center for Human Genetics, KU Leuven, Leuven, Belgium.
KU Leuven Institute for Single-cell Omics, KU Leuven, Leuven, Belgium.

Nicolas Rama (N)

Laboratory Apoptosis, Cancer and Development, Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institute PLAsCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Lyon, France.

Jens Van Herck (J)

Department of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.

Christine Dubois (C)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Samuel Scozzaro (S)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Sophie Lemaire (S)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Sarah Gieskes (S)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Sophie Bonni (S)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Amandine Collin (A)

DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Jumet, Belgium.

Nicolas Braissand (N)

NETRIS Pharma, Lyon, France.
Laboratory Apoptosis, Cancer and Development, Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institute PLAsCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Lyon, France.

Justine Allard (J)

DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Jumet, Belgium.

Egor Zindy (E)

DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Jumet, Belgium.

Christine Decaestecker (C)

DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Jumet, Belgium.
Laboratory of Image Synthesis and Analysis, Ecole Polytechnique-Université libre de Bruxelles (EPB-ULB), Gosselies, Belgium.

Christos Sotiriou (C)

Laboratory of Breast Cancer Translational Research J.-C. Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.

Isabelle Salmon (I)

DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Jumet, Belgium.
Centre Universitaire Inter Régional d'Expertise en Anatomie pathologique Hospitalière (CurePath), Brussels, Belgium.
Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Patrick Mehlen (P)

NETRIS Pharma, Lyon, France. patrick.mehlen@lyon.unicancer.fr.
Laboratory Apoptosis, Cancer and Development, Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institute PLAsCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Lyon, France. patrick.mehlen@lyon.unicancer.fr.

Thierry Voet (T)

Department of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.
KU Leuven Institute for Single-cell Omics, KU Leuven, Leuven, Belgium.

Agnès Bernet (A)

NETRIS Pharma, Lyon, France. agnes.bernet@lyon.unicancer.fr.
Laboratory Apoptosis, Cancer and Development, Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institute PLAsCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Lyon, France. agnes.bernet@lyon.unicancer.fr.

Cédric Blanpain (C)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium. cedric.blanpain@ulb.be.
WEL (Wallon ExceLlence) Research Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. cedric.blanpain@ulb.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH